Serious Bacterial Infections Associated with Eculizumab: A Pharmacovigilance Study
Conclusion Careful monitoring of serious bacterial infections associated with eculizumab treatment is warranted.PMID:37690847 | DOI:10.2169/internalmedicine.1893-23
Source: Internal Medicine - Category: Internal Medicine Authors: Shohei Okusa Tsubasa Takizawa Shungo Imai Munenori Oyama Kei Ishizuchi Jin Nakahara Satoko Hori Shigeaki Suzuki Source Type: research
More News: Databases & Libraries | Internal Medicine | Japan Health | Men | Meningitis | Myasthenia Gravis | Rituxan | Study | Toxic Shock Syndrome | Toxicology